Fraunhofer Institute for Toxicology and Experimental Medicine

BIO-Europe 2026

Partnering conference / November 09, 2026 - November 11, 2026

Fraunhofer ITEM at BIO-Europe 2026 – international gathering of biopharma professionals

From human-relevant preclinical models to clinical proof of concept

Meet our experts at BIO-Europe in Cologne and discover how Fraunhofer ITEM supports pharmaceutical and biotech companies across translational drug development, from preclinical efficacy and safety assessment to early clinical trials.

Event details

Location

Cologne, Germany

Date

November 09, 2026 - November 11, 2026

Download this event as iCal

Language

English

These are our topics at the BIO-Europe 2026

Human-Relevant Disease Models

Our Organoid & Tissue Research Center at Fraunhofer ITEM brings together native human tissues, organoids and standardized iPSC-derived immune cell models in an integrated platform for preclinical research.

Disease-relevant models for inflammation, fibrosis, infection and other indications provide human-relevant insights into efficacy, safety and mechanisms of action.

Learn more

Inhalation Toxicology

We are committed to provide customized solutions for aerosolization and testing of drug candidates including small molecules, recombinant proteins, cell and gene therapies or bacteriophages.

We are happy to support you as a reliable partner with our key expertise in:

Inhaled administration and (GLP-certified) toxicity assessment
Toxicokinetics of inhaled particles
Formulation analytics

With our inhouse-knowledge of histopathology, hematology and clinical chemistry, as well as our portfolio in safety pharmacology testing, we provide full preclinical service for translation to clinical phase trials.

Toxicology Testing

Translational Fibrosis Research

Advance the preclinical efficacy of antifibrotic therapeutics on human lung tissue for early human proof-of-concept.

Fibrosis Research

Clinical Trials & Proof-of-Concept Studies

We conduct early-phase and proof-of-concept clinical studies and combine clinical research with biomarkers, imaging, respiratory diagnostics and specialized challenge models to support evidence-based development decisions.

Learn More